Catherine Doherty sells DGX shares via Form 144
Catherine T. Doherty reported sales of Common Stock under a Form 144 filing.
Rhea-AI Filing Summary
Catherine T. Doherty reported sales of Common Stock under a Form 144 filing. The filing lists sales of $5,393,815.32 for 26,165 shares on 02/13/2026 and $293,521.39 for 1,433 shares on 02/19/2026.
The filing also shows 632 shares tied to restricted stock vesting dated 02/23/2026, identified as securities to be sold. The transactions are reported on a Form 144 related to Common shares.
Positive
- None.
Negative
- None.
Insights
Form 144 documents disclosed insider dispositions totaling 27,598 shares across February 2026.
Reported transactions include 26,165 shares sold on 02/13/2026 for $5,393,815.32 and 1,433 shares sold on 02/19/2026 for $293,521.39. The filing also lists 632 shares from restricted stock vesting dated 02/23/2026.
These entries are administrative disclosures of insider sales; cash‑flow treatment and buyer identities are not provided. Subsequent filings or broker confirmations would show execution details and whether planned 632‑share disposition occurred.
FAQ
What did Catherine T. Doherty report in the Form 144 for DGX?
Are sale proceeds disclosed in the Form 144 for these DGX trades?
Who is the broker or intermediary listed on the Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.